{
  "zip": "92108",
  "sector": "Healthcare",
  "longBusinessSummary": "Sigyn Therapeutics, Inc. operates as a therapeutic technology company that treats inflammatory conditions by cytokine storm syndrome. It offers Sigyn Therapy, a blood purification technology designed to mitigate cytokine storm syndrome through the broad-spectrum depletion of inflammatory targets from the bloodstream. Sigyn Therapeutics, Inc. was incorporated in 2019 and is based in San Diego, California.",
  "city": "San Diego",
  "phone": "619 368 2000",
  "state": "CA",
  "country": "United States",
  "companyOfficers": [],
  "website": "http://www.sigyntherapeutics.com",
  "maxAge": 1,
  "address1": "8880 Rio San Diego Drive",
  "industry": "Biotechnology",
  "address2": "Suite 800",
  "previousClose": 1.75,
  "regularMarketOpen": 1.51,
  "twoHundredDayAverage": 1.62,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 1.51,
  "navPrice": null,
  "averageDailyVolume10Day": 3540,
  "totalAssets": null,
  "regularMarketPreviousClose": 1.75,
  "fiftyDayAverage": 1.62,
  "trailingAnnualDividendRate": null,
  "open": 1.51,
  "averageVolume10days": 3540,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": null,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 1.51,
  "priceHint": 4,
  "currency": "USD",
  "regularMarketVolume": 500,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 51621160,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 3540,
  "priceToSalesTrailing12Months": null,
  "dayLow": 1.51,
  "ask": null,
  "ytdReturn": null,
  "askSize": null,
  "volume": 500,
  "fiftyTwoWeekHigh": 1.75,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 1.45,
  "bid": null,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": null,
  "dayHigh": 1.51,
  "exchange": "PNK",
  "shortName": "SIGYN THERAPEUTICS INC",
  "longName": "Sigyn Therapeutics, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "SIGY",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_685506704",
  "uuid": "f17d34da-468c-362b-9d00-ecc81b8cc48c",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": null,
  "beta3Year": null,
  "profitMargins": 0,
  "enterpriseToEbitda": null,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 34186200,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": null,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": null,
  "heldPercentInstitutions": 0.0021799998,
  "netIncomeToCommon": null,
  "trailingEps": null,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": null,
  "heldPercentInsiders": 0.110010006,
  "nextFiscalYearEnd": null,
  "mostRecentQuarter": 1601424000,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 53575828,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": null,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 1.51,
  "logo_url": "https://logo.clearbit.com/sigyntherapeutics.com"
}